1-4 of 4
J T Isaacs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).

C A Dionne, A M Camoratto, J P Jani, E Emerson, N Neff, J L Vaught, C Murakata, D Djakiew, J Lamb, S Bova, D George, J T Isaacs
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (8): 1887–1898.
Published: 01 August 1998
View article
PDF
Journal Articles

Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.

I B Joseph, J B Nelson, S R Denmeade, J T Isaacs
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (12): 2507–2511.
Published: 01 December 1997
View article
PDF
Journal Articles

Expression of bcl-2 and the progression of human and rodent prostatic cancers.

Y Furuya, S Krajewski, J I Epstein, J C Reed, J T Isaacs
Journal: Clinical Cancer Research
Clin Cancer Res (1996) 2 (2): 389–398.
Published: 01 February 1996
View article
PDF
Journal Articles

Implication of cell kinetic changes during the progression of human prostatic cancer.

R R Berges, J Vukanovic, J I Epstein, M CarMichel, L Cisek, D E Johnson, R W Veltri, P C Walsh, J T Isaacs
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (5): 473–480.
Published: 01 May 1995
View article
PDF